ARTICLE | Company News
Evotec BioSystems, Sugen deal
March 6, 2000 8:00 AM UTC
EVT will use its ultra-high throughput screening technology on Sugen's targets and compound libraries to find small molecules that inhibit phosphotyrosine phosphatase enzymes. EVT will receive upfront...